Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI

NCT06763172 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Healthy
Caffeine
Adenosine
Dopamine D2/3 Receptor Availability

Interventions

DRUG: Caffeine (200 mg)
DRUG: Placebo

Sponsor

Hsiao-Ying Wey